Economic benefit of Helicobacter pylori screening and eradication treatment for the prevention of gastric cancer
Project/Area Number |
22659098
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Medical sociology
|
Research Institution | Tohoku University |
Principal Investigator |
KOINUMA Nobuo 東北大学, 大学院・医学系研究科, 教授 (60134095)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,280,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2010: ¥1,200,000 (Direct Cost: ¥1,200,000)
|
Keywords | 胃癌 / 胃癌検診 / 医療経済 / 費用便益分析 / ヘリコバクター / ピロリ菌 / 胃がん / 胃がん検診 / ヘリコバクタ・ピロリ菌 / ピロリ菌除菌 / システムモデル |
Research Abstract |
The purpose of this study is to predict the economic benefit of an H. pylori eradication strategy as a method to prevent of gastric cancer. Using data in the literature and statistics such as patient survey and basic survey on wage structure, the number of those who developed gastric cancer by H. pylori was estimated and the cost benefit analysis was done. When the response rates of screening and eradication treatment are set at (30%, 60%), (20%, 40%), and (40%, 70%), the cost benefit ratios would be 0.9,1.6 and 0.7 respectively. When the response rates are high, the cost would be huge but would be recovered very quickly. The infection rate of H. pylori is gradually decreasing in younger people and it is necessary to consider the trend in the number of the infected people, the response rates of screening and that of eradication treatment for the economic evaluation.
|
Report
(4 results)
Research Products
(19 results)